OVERVIEW

Cardiovascular Institute (CVI) of Philadelphia 17th Annual Update in Nuclear Cardiology 2021 is organized by Cardiovascular Institute (CVI) of Philadelphia and will be held from Jun 06 - 09, 2021.

Target Audience:
Cardiologists, radiologists, nuclear medicine physicians, nuclear technologists, fellows, residents and mid-level providers involved in nuclear medicine. The program is also appropriate for all physicians and healthcare professionals who treat patients with coronary artery disease.

Accreditation:
Credit Designation Statement AMA:
Einstein Medical Center designates this live educational event for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the educational event.

AOA:
This program is eligible for 8.25 credits in category 2A of the American Osteopathic Association through the Pennsylvania Osteopathic Medical Association Foundation.

Medical Knowledge MOC Credits/Points:
Successful completion of this CME activity enables the participant to earn up to 7.5 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

• Session 1 – Sunday June 6, 2021 (3.5 Credits)
• Session 2 – Monday June 7, 2021 (2.25 Credits)
• Session 3 – Wednesday June 9, 2021 (2.5 Credits)
? 8.25 Nuclear-Specific CME Credits
? 8.25 Nuclear-Specific VOICE Credits
? 7.5 Medical Knowledge MOC Points for physicians who certify through ABIM

Why you should attend:
CVI’s 17th Annual Update in Nuclear Cardiology CME program is designed to further the clinical application, management and interpretation skills of physicians, nuclear technologists and mid-level providers involved in non-invasive cardiac imaging including SPECT, PET and Cardiac MR. The agenda for CVI’s 17th Annual Update in Nuclear Cardiology focuses on a variety of topics in non-invasive cardiac imaging including: Clinical Implications of the ISCHEMIA Trial, Test Accuracy on Stress SPECT Imaging, Differences Between CVT SPECT & SPECT, Transition from SPECT to PET, PET & PET/CT Artifacts, MBF Imaging, PET Reporting, PYP Imaging, Imaging for Managing Cardio-Oncology and Sarcoidosis.

Focus Topics:
• Implications of ISCHEMIA on Imaging
• Improving Test Accuracy on Stress Myocardial Perfusion SPECT Imaging
• Comparing CZT SPECT with Traditional SPECT
• Transitioning from SPECT to PET
• PET, PET/CT Artifacts
• 21st Century Myocardial Blood Flow Imaging
• PET Reporting
• PYP Imaging to Diagnose Amyloid
• Imaging to Manage Cardio Oncology
• Diagnosis and Management of Cardiac Sarcoidosis

Learning Objectives:
After attending CVI’s 17th Annual Update in Nuclear Cardiology, attendees will be better able to:
• Emphasize the importance of optimal medical therapy in obstructive coronary artery disease
• Develop a symptom-based management strategy for higher-risk patients with stable ischemic heart disease
• Highlight contemporary diagnostic and therapeutic options with attention to shared decision-making
• Describe the use of various techniques such as stress prone imaging and newer reconstructive software to improve study quality and diagnostic accuracy on stress myocardial perfusion SPECT imaging
• Explain the use of newer camera hardware systems to improve study quality and diagnostic accuracy on stress myocardial perfusion imaging with SPECT
• Discuss how iterative reconstruction and attenuation correction techniques for processing improve image quality
• Describe the principles of solid-state imaging
• Recognize common artifacts on CZT-crystal cameras
• Demonstrate the advantages of solid-state imaging
• Recognize the advantages of cardiac PET over SPECT myocardial perfusion imaging
• Demonstrate the value of PET derived myocardial flow reserve and when to report it
• Review the features of microvascular disease and allograft vasculopathy as assessed by PET derived myocardial flow reserve
• Identify sources of common PET and PET/CT Artifacts
• Recognize strategies for preventing these artifacts
• Develop strategies for differentiating artifact from perfusion features
• Define coronary flow capacity and explain how it differs from global or regional stress myocardial blood flow and CFR
• Describe subendocardial ischemia (SEI) new methods for imaging SEI and clinical outcomes
• Explain various definitions of micro vascular disease and how PET imaging can assist in diagnosis
• Review the importance of structured reporting
• Assemble critical components of a PET report
• Compose PET Summary statements and how to address discrepant findings
• Appropriately select patients for PYP imaging
• Describe the acquisition protocol for PYP Imaging
• Recognize the diagnostic SPECT findings for patients with cardiac amyloid
• Identify chemotherapeutic agents that have cardiotoxic side effects
• Apply imaging guidelines to monitoring of chemotherapeutic cardiotoxicity and management of chemotherapy
• Describe the strengths and weaknesses of different imaging modalities in the monitoring of cardiotoxicity
• Recognize the challenges inherent in diagnosing cardiac sarcoidosis
• Describe the role of cardiac MRI and PET in evaluation of patients with suspected cardiac sarcoidosis
• Utilize cardiac PET in selecting patients for immunosuppressive therapies and following response to therapy